Picture of Jubilant Pharmova logo

JUBLPHARMA — Jubilant Pharmova News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Jubilant Pharmova Says FDA Issued 8 Observations After Inspection Of Nanjangud Facility

Dec 14 (Reuters) - Jubilant Pharmova Ltd  JUBA.NS :
    * USFDA COMPLETES INSPECTION OF ITS API MANUFACTURING
FACILITY AT
NANJANGUD, INDIA
    * US FDA HAS ISSUED EIGHT OBSERVATIONS PURSUANT TO
COMPLETION OF
INSPECTION
    * COMPANY WILL SUBMIT AN ACTION PLAN ON OBSERVATIONS AND
WILL
ENGAGE WITH US FDA FOR NEXT STEPS

Source text for Eikon:  ID:nBSE8NyYKW 
Further company coverage:  JUBA.NS 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Jubilant Pharmova

See all news